{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:39Z","timestamp":1792068879781,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Gm 13\/13\\u201310"],"award-info":[{"award-number":["Gm 13\/13\\u201310"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmc.2026.118783","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:53:15Z","timestamp":1787388795000},"page":"118783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of covalent agonists for the muscarinic acetylcholine receptor"],"prefix":"10.1016","volume":"143","author":[{"given":"Katrin","family":"Eitel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Risel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Kaindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Einsiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gmeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118783_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/60300142","article-title":"Muscarinic receptor agonists and antagonists","volume":"6","author":"Broadley","year":"2001","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bmc.2026.118783_bb0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41573-024-01007-1","article-title":"A golden age of muscarinic acetylcholine receptor modulation in neurological diseases","volume":"23","author":"Tobin","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.bmc.2026.118783_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/ph18030369","article-title":"A new era of muscarinic acetylcholine receptor modulators in neurological diseases, Cancer and drug abuse","volume":"18","author":"Tsimpili","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.bmc.2026.118783_bb0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.bmc.2026.118783_bb0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.bmc.2026.118783_bb0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(93)90027-B","article-title":"Muscarinic receptors-characterization, coupling and function","volume":"58","author":"Caulfield","year":"1993","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bmc.2026.118783_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","article-title":"Therapeutic effect of cevimeline on dry eye in patients with Sj\u00f6gren\u2019s syndrome: a randomized, double-blind clinical study","volume":"138","author":"Ono","year":"2004","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.bmc.2026.118783_bb0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"13","key":"10.1016\/j.bmc.2026.118783_bb0045","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.bmc.2019.05.034","article-title":"Development of covalent antagonists for \u03b21- and \u03b22-adrenergic receptors","volume":"27","author":"Schwalbe","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.bmc.2026.118783_bb0050","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.bmc.2017.06.034","article-title":"Potent haloperidol derivatives covalently binding to the dopamine D2 receptor","volume":"25","author":"Schwalbe","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"29","key":"10.1016\/j.bmc.2026.118783_bb0055","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1073\/pnas.1410415111","article-title":"Covalent agonists for studying G protein-coupled receptor activation","volume":"111","author":"Weichert","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7329","key":"10.1016\/j.bmc.2026.118783_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature09665","article-title":"Structure and function of an irreversible agonist-\u03b2(2) adrenoceptor complex","volume":"469","author":"Rosenbaum","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bmc.2026.118783_bb0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acschembio.5b00965","article-title":"Development of covalent ligand\u2013receptor pairs to study the binding properties of nonpeptidic neurotensin receptor 1 antagonists","volume":"11","author":"Kling","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bmc.2026.118783_bb0070","doi-asserted-by":"crossref","first-page":"116720","DOI":"10.1016\/j.bmc.2022.116720","article-title":"Development of disulfide-functionalized peptides covalently binding G protein-coupled receptors","volume":"61","author":"Einsiedel","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmc.2026.118783_bb0075","doi-asserted-by":"crossref","unstructured":"Garg MK, Kharb S, Brar KS, Gundgurthi A, Mittal R. Medical management of pheochromocytoma: role of the endocrinologist. Indian J Endocrinol Metab 2011;15 Suppl 4(Suppl4):S329\u201336. doi:https:\/\/doi.org\/10.4103\/2230-8210.86976.","DOI":"10.4103\/2230-8210.86976"},{"issue":"6","key":"10.1016\/j.bmc.2026.118783_bb0080","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/S0021-9258(17)41747-9","article-title":"Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors","volume":"269","author":"Spalding","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bmc.2026.118783_bb0085","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/jm00281a026","article-title":"Syntheses and pharmacological actions of 2-((2-chloroethyl)methylamino)ethyl acetate and some of its derivatives on the isolated guinea pig ileum","volume":"15","author":"Jackson","year":"1972","journal-title":"J. Med. Chem."},{"issue":"7478","key":"10.1016\/j.bmc.2026.118783_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12735","article-title":"Activation and allosteric modulation of a muscarinic acetylcholine receptor","volume":"504","author":"Kruse","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bmc.2026.118783_bb0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X","article-title":"Soft drug design: general principles and recent applications","volume":"20","author":"Bodor","year":"2000","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.bmc.2026.118783_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molcel.2019.04.028","article-title":"Conformational complexity and dynamics in a muscarinic receptor revealed by NMR spectroscopy","volume":"75","author":"Xu","year":"2019","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bmc.2026.118783_bb0105","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1021\/acs.orglett.9b00156","article-title":"Silver-catalyzed Carboxylative cyclization of primary propargyl alcohols with CO2","volume":"21","author":"Dabral","year":"2019","journal-title":"Org. Lett."},{"issue":"13","key":"10.1016\/j.bmc.2026.118783_bb0110","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1039\/b902863c","article-title":"Synthesis and monoamine uptake inhibition of conformationally constrained 2beta-carbomethoxy-3beta-phenyl tropanes","volume":"7","author":"Riss","year":"2009","journal-title":"Org. Biomol. Chem."},{"issue":"7","key":"10.1016\/j.bmc.2026.118783_bb0115","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/acs.bioconjchem.8b00074","article-title":"Beyond gene transfection with methacrylate-based polyplexes-the influence of the amino substitution pattern","volume":"29","author":"Tr\u00fctzschler","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"6604 Suppl","key":"10.1016\/j.bmc.2026.118783_bb0120","first-page":"14","article-title":"High-throughput screening for drug discovery","volume":"384","author":"Broach","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118783_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2024.100770","article-title":"Efficacy of cevimeline on xerostomia in Sj\u00f6gren\u2019s syndrome patients: a systematic review and Meta-analysis of randomized clinical trials","volume":"102","author":"Karimi","year":"2025","journal-title":"Curr. Ther. Res."},{"issue":"suppl 3","key":"10.1016\/j.bmc.2026.118783_bb0130","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.33549\/physiolres.931449","article-title":"Importance and prospects for design of selective muscarinic agonists","volume":"57","author":"Jakub\u00edk","year":"2008","journal-title":"Physiol. Res."},{"issue":"1","key":"10.1016\/j.bmc.2026.118783_bb0135","first-page":"151","article-title":"Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Bacman","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.bmc.2026.118783_bb0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/jm991098z","article-title":"Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D3 subtype","volume":"43","author":"H\u00fcbner","year":"2000","journal-title":"J. Med. Chem."},{"issue":"47","key":"10.1016\/j.bmc.2026.118783_bb0145","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1073\/pnas.1813988115","article-title":"Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bmc.2026.118783_bb0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bmc.2026.118783_bb0155","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bmc.2026.118783_bb0160","series-title":"Gaussian 09, Revision B.01","author":"Frisch","year":"2009"},{"issue":"2","key":"10.1016\/j.bmc.2026.118783_bb0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:37:43Z","timestamp":1792067863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S0968089626002397"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118783","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of covalent agonists for the muscarinic acetylcholine receptor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118783"}}